Background: Enhanced-depth imaging optical coherence tomography (EDI-OCT) provides high-resolution imaging of the choroid. Herein, we report multimodal imaging, including EDI-OCT, of a case of sarcoid choroidal granulomas.
Introduction
Choroidal granulomas in the absence of anterior uveitis are a rare but well-recognized manifestation of sarcoidosis, occurring in approximately 5% of patients with ocular sarcoidosis [1] . Accurate imaging to correctly differentiate granulomas from amelanotic melanomas and choroidal metastasis is critical prior to developing a treatment plan. Enhanced-depth imaging optical coherence tomography (EDI-OCT), a novel imaging modality that provides excellent morphologic details of the choroid, has recently been used to evaluate choroidal pathology in various disease states including central serous chorioretinopathy [2] , myopia [3] , macular degeneration [4] , choroidal tumors [5] , and a Toxocara optic nerve granuloma [6] . However, EDI-OCT imaging of choroidal granulomas in the setting of sarcoidosis has not been previously reported.
Herein, we report a case of unilateral multifocal choroidal sarcoid granulomas that underwent multimodal imaging including EDI-OCT, fluorescein angiography (FA), and indocyanine green angiography (ICG).
Report of a case
A 63-year-old black female with recently diagnosed biopsy-supported systemic sarcoidosis involving the lungs and skin presented with an insidious, painless decrease in vision of the right eye with metamorphopsia over a 3-month period. A recent medical evaluation revealed lymphadenopathy on chest computed tomography, erythema nodosum of the lower extremities, and a skin biopsy demonstrating noncaseating granulomas consistent with sarcoidosis. She had not started any systemic immunosuppression at the time of presentation. The patient consented for this case to be presented. Given the medical and ophthalmic work-up favoring sarcoidosis with multifocal choroidal granulomas, the patient was started on 60 mg of oral prednisone with a weekly taper of 10-mg decrements. Five weeks after presentation, the patient's metamorphopsia had resolved, with BCVA improving to 20/25. The elevated choroidal lesions had resolved along with the SRF, but there was mild hypopigmentation over the lesion sites (Figure 2a) . SD-OCT (Figure 2b ) through the same area demonstrated resolution of the choroidal granuloma. EDI-OCT (Figure 2c ) demonstrated the posterior margin of the choroid, absence of the hyporeflective lesion, and normal architecture. However, ICG (Figure 2d ) demonstrated persistent choroidal hypofluoresence corresponding to the original lesion sites. The optic disc leakage had resolved, however (Figure 2d) .
The patient refused methotrexate as a steroid-sparing alternative and was subsequently maintained on 5 mg of prednisone daily with no recurrence of the choroidal granulomas. Twelve months after presentation, the choroidal granulomas did not recur. Repeat ICG (Figure 3 ) demonstrated significantly improved but still present hypofluorescence.
Discussion
Choroidal granulomas manifesting as the sole lesion in ocular sarcoidosis has been previously described [1, [7] [8] [9] [10] . Desai et al. reported on the largest case series of choroidal granulomas in nine patients with biopsy-proven sarcoidosis [1] . Eight patients presented with solitary choroidal granulomas, and one patient presented with multifocal involvement. All the patients were started on oral prednisone with nine out of nine eyes demonstrating a reduction in size of the granuloma and two out of nine eyes demonstrating complete resolution. Five of the eyes experienced a recurrence, however, with an average time to recurrence of 7.6 months [1] .
EDI-OCT imaging of the choroid, in this case, provided accurate morphologic characterization of the choroidal granuloma and its subsequent resolution. Salman et al. previously characterized tuberculous granulomas via a Stratus OCT (Carl Zeiss Meditec Inc., Dublin, CA, USA), which demonstrated the relationship of the anterior granuloma with the RPE and retina [11] . However, the morphology and the posterior margin were not well characterized. The resolving ability of EDI-OCT for choroidal lesions has been reported as 1 mm in depth, allowing for accurate qualitative and quantitative evaluation of small choroidal lesions too small to be characterized via ultrasound [12] . Additionally, EDI-OCT may provide the ability to detect interval change of the granuloma size in response to treatment and, potentially, early recurrence.
After 1 month of treatment on oral steroids, the granulomas in this patient clinically disappeared with residual RPE mottling and hypopigmentation over the sites of prior granulomas. Repeat imaging via EDI-OCT demonstrated resolution of the lesion with an apparent return of normal choroidal architecture. The ICG, however, continued to demonstrate hypofluorescence in the involved sites 11 months after clinical resolution. It is possible that this may represent a longstanding choroidal perfusion deficit that cannot be resolved via OCT. Subsequent EDI-OCT has not demonstrated early recurrence of these lesions, and the patient will continue maintenance therapy with low-dose steroids.
In conclusion, choroidal imaging via EDI-OCT provides detailed morphologic information of sarcoid granulomas and can accurately demonstrate structural resolution of the lesions. Further studies are required to identify defining features that may aid in differentiation from other inflammatory and neoplastic processes.
